AmBisome

This page contains recent news articles, when available, and an overview of AmBisome but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

מ×?וחדת דחתה הטיפול בשל עלותו - החולה מתה  -  ‎Dec 20, 2009‎
...הרופ×?×™×? שטיפלו בו המליצו לו על טיפול בתרופה יקרה ((Ambisome, הניתנת בעירוי בבית חולי×? ונכללת בסל שירותי הברי×?ות. תרופה זו חיונית, קבעו, כדי למנוע סיבוכי×? ... ynet ידיעות אחרונות

10 μεγαλÏ?τεÏ?ες ανθÏ?ωπιστικές κÏ?ίσεις του 2009  -  ‎Dec 23, 2009‎
Η πολÏ? αποτελεσματική αγωγή για την ασθένεια αυτή, AmBisome, είναι ιδιαίτεÏ?α ακÏ?ιβή (κοστίζει στους ΓΧΣ από 450 ως 2.500 δολάÏ?ια ανά ασθενή, ... Γιατροί Χωρίς Σύνορα

ÄRZTE OHNE GRENZEN veröffentlicht Liste der schwersten humanitären Krisen 2009 ...  -  ‎Dec 21, 2009‎
Liposomal Amphotericin B (AmBisome) gewährleistet eine hocheffiziente Behandlung, wird aber aufgrund der hohen Kosten und aufwändigen Logistik nicht auf ... PresseEcho.de (Pressemitteilung)

Gilead Sciences Q3 Profit Rises, Tops Estimate  -  ‎Oct 20, 2009‎
Gilead said quarterly sales for Letairis, a pulmonary arterial hypertension treatment, surged 52% to $48.1 million and sales of AmBisome liposome for ... Trading Markets (press release)

SanDisk Announces Third Quarter 2009 Financial Results  -  ‎Oct 20, 2009‎
1644407 1188497 Total Antiviral products - Other International 82066 72053 239645 209389 1470231 1231533 4221278 3399597 AmBisome 77064 72884 214645 ... Reuters

GileadSciencesgibtRekord-Finanzergebnis für das dritteQuartal2009bekannt  -  ‎Oct 23, 2009‎
Truvada, Viread, Hepsera, AmBisome, Letairis, Ranexa und Cayston sind eingetragene Marken von Gilead Sciences, Inc. Atripla ist eine eingetragene Marke von ... Reuters

GileadSciencesannonce des résultats financiers record pour le troisième ...  -  ‎Oct 23, 2009‎
Truvada, Viread, Emtriva, Hepsera, AmBisome, Letairis, Ranexa et Cayston sont des marques déposées de Gilead Sciences, Inc. Atripla est une marque déposée ... Reuters

BUSINESS WIRE: Gilead Sciences gibt Rekord-Finanzergebnis für das dritte ...  -  ‎Oct 23, 2009‎
82.066 72.053 239.645 209.389 international 1.470.231 1.231.533 4.221.278 3.399.597 AmBisome 77.064 72.884 214.645 213.680 Letairis 48.073 31.656 ... Vereinigte Wirtschaftsdienste





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy